Ioxilan

Drug Profile

Ioxilan

Alternative Names: Imagenil; Oxilan

Latest Information Update: 27 May 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Cook Imaging Corporation
  • Developer Cook Imaging Corporation; Guerbet; Japan Tobacco; Kyowa Hakko Kirin; Mitsubishi Tanabe Pharma Corporation
  • Class Nonionic contrast media; Small molecules; Triiodobenzoic acids
  • Mechanism of Action Radiography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Vascular disorders

Most Recent Events

  • 27 May 2010 Launched for Vascular disorders (diagnosis) in Canada (IV)
  • 01 Oct 2008 Kirin Pharma Company has merged with Kyowa Hakko to form Kyowa Hakko Kirin
  • 01 Oct 2007 Mitsubishi Pharma Corporation has merged with Tanabe Seiyaku to form Mitsubishi Tanabe Pharma Corporation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top